Factor Product Utilization and Health Outcomes in Patients With Hemophilia A and B in Canada: An Observational Study of Real-world Outcomes
Latest Information Update: 30 Apr 2021
At a glance
- Drugs Efmoroctocog alfa (Primary) ; Eftrenonacog alfa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Therapeutic Use
- 26 Apr 2021 Status changed from recruiting to completed.
- 26 Oct 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 26 Oct 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.